Stock Quote. NASDAQ: TBPH. $9.14 -0.03 (0.00%). Volume :387,247.
Feb 22, 2024 · PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual ...
Find annual and quearterly earnings data for Theravance Biopharma, Inc. Ordinary Shares (TBPH) including earnings per share, earnings forecasts at ...
Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn more.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
People also ask
What does Theravance Biopharma do?
Where is Theravance Biopharma located?
Who is the CEO of Theravance Biopharma?
What is the email format for Theravance Biopharma?
Dec 21, 2023 · ("Theravance" or the "Company") (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a ...
Feb 23, 2022 · ... TBPH implied 35%. 8. TBPH implied 35% of YUPELRI US net sales represents TBPH's portion of the combined TBPH and VIATRIS net revenue. TBPH. Im.
Missing: relations | Show results with:relations